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Despite past decades of steady advances in the fight against Malaria, statistics show that the disease is 
still a threat to human health. Previous successes in the development of antimalarial drugs from 
medicinal plants have fuelled research in this area. However, antimalarial studies on fractionated 
extracts from such plants have progressed slowly. This study reports the antimalarial potential of 
fractions from Lippia kituiensis Vatke, for the first time. Column chromatography was used during 
fractionation. Antiplasmodial assay against chloroquine-sensitive (D6) and resistant (W2) plasmodium 
strains were done using hypoxanthine incorporation assay. MTT assay was used to assess the 
cytotoxicity of fractions against the Vero cell line. Fractions obtained exhibited varied inhibitory 
concentrations (IC50); with the most efficacious being, Lk-5 (19.45 ± 6.20 μg/ml), Lk-3 (30.43 ± 0.68 
μg/ml), Lk-4 (30.82 ± 18.01 μg/ml), and Lk-6 (36.53 ± 14.42 μg/ml) against D6. Generally, lower activity 
against W2 was obtained with the most active being LK-4 (24.18±2.50 μg/ml), and Lk-5 (24.42±5.95 
μg/ml), while chloroquine (positive control) exerted IC50 of 77.86±4.09 ng/ml (W2) and 15.71±6.49 ng/ml 
(D6). LK-4 was the most cytotoxic showing cytotoxic concentration (CC50), 46.26 μg/ml. When tested in 
mice, fractions suppressed Plasmodium berghei significantly compared to the negative control with Lk-
3 being most efficacious (80.01±1). Due to substantive efficacy, GC-MS done on Lk-3 revealed 8 
compounds where three have previously been ascribed to antimalarial activity and other 
pharmacological effects. This study adds to present knowledge of antimalarial efficacy of L. kituiensis 
and provides the basis for further work to be done on the isolation of compounds from its extracts. 
 





The fight against malaria is at a critical point with an 
estimated  2  million  increase  in  global  cases   between 
2016 and 2017 alone. Africa is continuously the most 
affected  with  92%  of  global  cases  happening   in   the 
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continent. Among 80% of Malaria deaths in 17 countries 
of Sub-Sahara Africa and India, 5% happened in the 
United Republic of Tanzania (World Health Organization, 
2018). This possible global resurgence of malaria spells a 
looming crisis in human health particularly in the African 
continent (World Malaria Day, 2019). 
The disease is caused by Plasmodium falciparum, 
Plasmodium ovale, Plasmodium vivax, Plasmodium 
malariae and Plasmodium knowlesi all of which are 
transmitted by the bites of Plasmodium spp. infected 
female mosquitoes of the Anopheles genus (Singh et al., 
2004; Van Hellemond et al., 2009). However, P. 
falciparum and P. vivax, for which humans are exclusive 
mammalian hosts, are responsible for the largest public 
health burden (Phillips et al., 2017). Furthermore, the 
recent emergence of malaria as a zoonosis due to P. 
knowlesi transmission poses obvious complications for 
elimination (Imwong et al., 2011). With currently no 
approved vaccine, chemotherapy and, prevention are 
predominant methods of malaria control (Chen et al., 
2018). 
Artemisinin has been the cornerstone of malaria 
chemotherapy. However, worrying reports of failure 
attributed to growing resistance have been published; 
highlighting a clear need to find alternative treatment 
options that are effective, well-tolerated, and safe 
(Landier et al., 2018; Pereira et al., 2011). Additionally, 
the previously cheap and effective drugs like chloroquine 
are no longer effective due to the rapid spread of the 
resistant Plasmodium strains. Even with existing reports 
of vaccine development, chemotherapy will still be 
required. More urgently, new and robust anti- malarial 
drugs, acting on new targets that have not been mutated 
into resistant forms, are urgently needed (De Beer et al., 
2012). 
Plants present a wealth of compounds with novel 
mechanisms of action (Bero et al., 2009), hence this 
particular study. Lippia is a genus of flowering plants in 
the family Verbenaceae, known for its characteristic 
aromaticity from its essential oil (Arthur et al., 2011). With 
approximately 200 species, Verbenaceae consists of 
herbs, shrubs and small trees. These species are mainly 
distributed throughout tropical African countries and 
South and Central American territories (Pascual et al., 
2001). Several studies have reported pharmacological 
effects of lippia including antimalarial, antimicrobial, 
antifungal, analgesic, larvicidal, antispasmodic, 
inflammatory, and antipyretic activities (Stashenko et al., 
2013). Lippia kituiensis is used by local communities in 
Tanzania to treat malaria, with only a single study 
reporting scientific validation of the efficacy of its total 
extracts. The current study reports the antimalarial 
efficacy of the fractions obtained from L. kituiensis. This 
is a subsequent study guided by previous report showing 
a significant chemo-suppression (95.19%) efficacy of 
total extracts of the plant against Plasmodium berghei 
(Mzena et al., 2018). 




Reagents and chemicals 
 
Silica gel powder (70-230 mesh), pre-coated Thin Layer 
Chromatography Plates, solvents (Hexane, Ethyl Acetate, 
Dichloromethane and, Methanol) and biological reagents 
and consumables were purchased from Sigma Aldrich. 
Chloroquine diphosphate and radio-labeled Hypoxanthine 
Monohydrate salt were generously donated by Dr. 
Gathirwa of the Kenya Medical Research Institute. 
 
 




Approvals for the study were obtained from Kenya Medical 
Research Institute’s Review Board which are, Scientific and Ethics 
Review Unit (SERU) approval number-
KEMRI/SERU/CTMDR/063/3644 and the Animal Care and Use 
Committee (ACUC)-KEMRI/ACUC/01.02.19.  
 
 
Collection and preparation of plant material 
 
Previous studies by Mzena et al. (2018) demonstrated significant 
antimalarial activity of total extracts of L. kituiensisVatke leading to 
this study. Samples of fresh aerial parts of the plant were harvested 
sustainably from Ugweno village in Kilimanjaro region, Northern 
Tanzania (3° 39’ 0” South and 37° 39’ 0”), where they are 
traditionally used to treat Malaria. The samples were harvested in 
the morning hours of 13th March 2018 and transported to NM-AIST. 
Identification and authentication of the plant were done with 
assistance from a resident herbalists and a professional taxonomist 
(Mr Josephat Mboya of the Tropical Research Institutes, Arusha). A 
voucher specimen was taken and deposited at the Nelson Mandela 
African Institute of Science and Technology and assigned specimen 
number LKV-160-2018. Soil and other contaminants were washed 
off using cold water. The plant material was dried under shade till 
complete dryness, milled into a fine powder and packed in manila 
bags. The sample was then stored at room temperature. The 
powdered plant material was transported to the Kenya Medical 
Research Institute, Nairobi where subsequent studies were done. 
 
 
Extraction of plant material 
 
Organic extraction was done with brief modifications of the method 
described by Gebrehiwot et al. (2019). Briefly, a top pan balance 
(Slater model-323, China), was used to weigh 1 kg of plant powder 
into a 5 L flat-bottomed flask. Methanol (MeOH) and 
Dichloromethane (DCM) mixture in the ratio 1:1 was used to 
macerate the plant material. This is because methanol being a 
polar solvent would extract polar compounds while DCM (non-polar) 
would extract the non-polar secondary metabolites. The powdered 
material was extracted for 24 h at room temperature and this was 
repeated two times. The material was filtered using Whatman’s filter 
paper (No. 1), and concentrated at reduced pressure using a rotary 
evaporator (BUCHI Rotavapor model No. R-114; Switzerland) 




Thin layer chromatography 
 
A small portion of the total extract of L. kituiensis Vatke was 
reconstituted in MeOH:  Dichloromethane  mixture  and  spotted  on 




cut pieces of pre-coated thin layer chromatography plates (TLC). 
The plates were then developed in different solvent pairs (Begum et 
al., 2017). Upon development, assessment of plates was done by 
observation on open light, under UV (254 and 365 nm), and after 
vanillin spray with plates heated to 110°C for 5 min. Based on 
retention factors (Rf) obtained from developed plates, the best 
solvent mixture to run the column was identified. Hexane and Ethyl 
acetate mixed in the ratio 4:1 gave the best separations and hence 






Open column chromatography was used to separate the total 
extract where briefly, a glass column of diameter 10 cm was packed 
with a slurry of 300 g of Silica powder (70-230 mesh, using100% 
Hexane) (Walker et al., 2015). The slurry was immediately 
transferred into the column with intermittent swirling to prevent 
solidification. The wetness of the gel was maintained by several 
elutions of 100% hexane. After 24 h of undisturbed packing, 
Hexane was drained and 60 g of the total extract of L. kituiensis 
was mixed with 70 g of silica and 100% hexane. The mixture was 
swirled to homogeneity and transferred into the packed column. 
500 ml of 100% hexane was then loaded into the column to begin 
fractionation as fractions were collected in different flasks. The 
polarity of the mobile phase was progressively increased until no 
further separations could be identified as guided by TLC profiles 
gathered in the process. 
 
 
In-vitro antiplasmodial assay 
 
Antiplasmodial activity of fractions was done using a semi-
automated microdilution technique on culture-adapted P. falciparum 
D6 (chloroquine-sensitive) and W2 (chloroquine-resistant) strains 
as earlier described by (Desjardins et al., 1979). Briefly, culture 
media consisted of RPMI 1640, 25 MM HEPES at pH 7.4, 
supplemented with 12.5% heat-inactivated human serum (obtained 
from pooled blood types A, AB and, O). Haematocrit was adjusted 
to 6% human erythrocytes (O
+ 
type RBCs) of 5 ml total culture 
volume. Cultures were kept in sealed flasks at 37°C, supplied with a 
gas mixture (3% O2, 5% CO2 and 92% N2). Stock solutions of drugs 
were prepared at 100 mg/ml in DMSO diluted by RPM1640 to attain 
a final 0.2% content of DMSO. Test samples were diluted in DMSO 
except for CQ; (constituted in water) and reduced to < 0.2% DMSO 
content. 25 µl of screening medium was then added to each well in 
a 96-well flat-bottom micro-culture plate (Costar®, Corning 
Incorporated, NY, U.S.A). 50 µl of constituted test samples at a 
starting concentration of 100 µg/ml was added to wells of row B in 
duplicate. Upon proper mixing, 25 µl of drug solution was 
transferred from wells of row B to wells of row C successively to row 
H.  200 µl of infected erythrocytes (1.5% hematocrit and 0.5% 
parasitemia) were then added to each well except for wells A9 to 
A12, to which, 200 µl of uninfected RBCs (diluted in screening 
medium to 1.5% hematocrit) were added as a negative control. The 
plates were incubated at 37°C in a chamber gassed by gas mixture 
at 95% humidity. After 48 h of incubation, 25 µl of [3H] 
hypoxanthine was added by pulsing to each well (0.5 µCi per well).  
Plates were incubated for a further 18 h after which it was frozen to 
negative 20°C. The plates were then thawed and the contents 
harvested onto glass-fiber filter mats (A 1450-421; Perkin Elmer) 
using a Betaplate cell harvester (1295-004 Betaplate; Wallac Perkin 
Elmer) The filter mats were then oven-dried and drenched in 10 ml 
of scintillation fluid (Beta Scintilla®, Perkin Elmer, Schwerzenbach, 
CH) while in a plastic foil (1450-432; Perkin Elmer). A Betaplate 
liquid scintillation counter (1205 Betaplate; Wallac Perkin Elmer) 





was measured in terms of counts per minute (cpm). The result of 
each well was recorded as counts per minute and expressed as a 
percentage of the untreated (positive) control (wells A1 to A8; 
cultures without test compound). Negative control was used for 
background subtraction. IC50s (drug concentration at which 50% of 
[3H] hypoxanthine incorporation was inhibited compared to drug-
free controls) were estimated by linear interpolation. 
 
 
Cell culture and cytotoxicity assay 
 
MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 
assay, which measures the conversion of MTT into formazan 
crystals by living cells, hence determining mitochondrial activity 
was used to asses cytotoxic levels of fractions as earlier described 
by Kaur et al. (2018). Vero (E6) cell line was grown in Dulbecco’s 
modified Eagle’s medium supplemented with 10% heat-inactivated 
Fetal bovine serum (Himedia), l-Glutamine and treated with 
penicillin/streptomycin (100 µgml
−1
), gentamycin (100 μgml
-1
). 
Culture flasks were incubated in a CO2 incubator (5% CO2; 90% 
Relative Humidity) at 37°C. Upon attainment of maximum 
confluence (90-100%), the cell monolayer was trypsinized and 
seeded at 2 × 10
5
 cells/ml in each well of 96-well plates and 
incubated at the same conditions for 24 h. Drug concentrations 
were prepared (1000μg/ml), seeded at the highest concentration 
and serial diluted to afford different concentrations across the plate. 
The plates were further incubated for 48 h after which 10 µl of MTT 
solution (5 mgml
−1
) added into each well and incubated for a further 
4 h. The plates were emptied of media and the formazan product 
was dissolved in 100 μl of neat Dimethyl sulfoxide (DMSO) seeded 
per well and shaken for 5 min. Optical density was measured using 
a microplate reader at 550 nm using a Thermofisher, MultiscanGo 
Spectrophotometer model. Inhibition data were plotted as dose-
response curves, from which CC50 (concentration required to cause 
alterations in 50% of intact cells) was estimated. Selectivity index 
(SI=IC50/CC50) a parameter that measures the clinical significance 
of the test samples by comparing general toxins and selective 




In-vivo antimalarial assays 
 
Dosages for in-vivo assay were prepared in a vehicle composed of 
10% Tween 80, 3% DMSO and PBS. The vehicle served as the 
negative control in each case respectively. We adopted a model 
involving the use of  P. berghei NK65 strain to study in vivo 
antimalarial activity on Swiss albino mice according to Peter’s 4-day 
suppressive test (Peters, 1975). Upon attainment of ethical 
approvals, Naïve Swiss albino mice weighing 20±2 g were 
acclimatized for 48 h. Frozen stabilates of P. berghei were thawed 
and injected into a group of 3 animals for propagation. Assessment 
of parasite growth was done microscopically and upon attainment 
of approximately 20% parasitaemia, blood was drawn from the 
passage mice (parasite donors) by cardiac puncture and 
reconstituted to 2% in phosphate saline glucose. Each of the 40 
mice was injected in the peritoneal cavity with 0.2 ml of infected 
blood at approximately 2×10
7  
P. berghei on day 0. Animals were 
then randomized into cages of 5 each that is, positive control 
(chloroquine 10 mg/kg), negative control and the 6 fraction-test 
groups which received 1000 and 500 mg/kg of test groups. All 
cages were well labeled with experimental details and animals 
supplied with clean water and standard rodent pellets. Stainless 
steel, 22-gauge cannula (Harvard Apparatus; needle of length = 
25.4 mm, ball diameter = 1.25 mm) was used for oral administration 
of drugs 2 h after infection. This continued on days 1 to 3 (24, 48 
and 72 h. Drug administration was stopped after 96 h since 
infection. On day 4, microscopic slides  were  prepared  by  drawing








Number of fractions 
combined 
Weights of fractions           
(g) 
Percentage yield of 
fractions 
      Physical  
    appearance   
Lk-1 3 3.48 3.96    Dark green gum 
Lk-2 6 5.07 5.77    Dark green gum 
Lk-3 3 2.05 2.33    Dark Yellow paste 
Lk-4 4 3.60 4.10    Dark green paste 
Lk-5 5 3.34 3.80    Dark green paste 




blood from tail veins. Slides were fixed in methanol, stained using 
10% Giemsa for 15 min. Parasitemia in each group was assessed 
microscopically under high magnification and oil immersion. 
Percentage chemosuppression of fractions was calculated with 
mean parasitemia on day 4 as described by Tona et al. (2001). 
 
 
Qualitative phytochemical screening  
 
Qualitative assessment of secondary metabolites present in the 
fractions was done using standard chemical procedures and tests 
(Kasolo et al., 2011). Availability or absence of alkaloids, tannins, 





Fraction Lk-3 (dark yellow paste) exhibited outstanding antimalarial 
activity against P. berghei at an oral dose of 1000mg/kg. A sample 
from this fraction was therefore subjected to FTIR at Jomo Kenyatta 
University of Agriculture, Science, and Technology (JKUAT). The 
Shimadzu FTIR spectrophotometer (FTS- 8000, Japan) was used 
to analyse the functional groups as done by Memon et al. (2015). 
The standard KBr disc method was used, where briefly, crystal 
sample was ground with KBr in the ratio 1 to 10 mg respectively. 
The mixture was pressed into a pellet using a hydraulic press and 
scanned with a spectral resolution set at 4 cm
–1
 and the scanning 







GC-MS at JKUAT was used to further determine compounds in 
fraction Lk-3. This was done as in earlier method (Igwe, 2015). A 
Shimadzu QP 2010-SE GC-MS coupled to an autosampler was 
used for analysis. Ultrapure Helium was used as the carrier gas at a 
flow rate of 1 ml / minute. A BPX5 (non-polar column, 30 m; 0.25 
mm ID; 0.25 µm film thickness) was used for separation. The GC 
was programmed as follows: 50°C (1 min); 5°C /min to 250°C (1 
min). Total runtime was 42 min. Injection temperature was set to 
200°C, while the interface temperature was set at 250°C. The EI ion 
source was set at 2000C and mass analysis was done in full scan 
mode, 50-550amu. The National Institute of Advanced Industrial 
Science and Technology (NAIST) 2014 library of mass spectra was 





Data are presented as mean± standard deviation. Analsysis of in 
vivo antimalarial assay was carried using Windows SPSS Version 
20.One-way analysis of variance (ANOVA) followed by Tukey's  test 
was done to determine statistical significance for comparison of 
parasitaemia suppression between groups. P value at <0.05 was 





A total of 32 fractions were obtained and concentrated as 
described previously. The combination of fractions was 
guided by TLC profile, where fractions that showed 
similar retention factors were pooled together. Eventually, 
6 fractions were obtained as summarised in Table 1. 
Under 254 nm of UV, fractions Lk-4 and largely Lk-5 
showed fluorescent spots. Preliminary in vitro 
antiplasmodial assay was conducted against culture-
maintained W2 (chloroquine-resistant) and D6 
(chloroquine-sensitive) strains of P. falciparum. 
Chloroquine diphosphate was used as the positive 
control while DMSO (0.2%) was the negative control. 
Results are shown in Table 2. 
The fractions exhibited moderate to low activity; where 
efficacy was classified as high at IC50 ≤10 µg/ml, 
moderate at 10-50 µg/ml, low at 50-100 µg/ml and 
inactive at >100 µg/ml, (Berthi et al., 2018). Generally, 
fraction LK-5 showed the highest antiplasmodial activity 
against chloroquine-sensitive strain (D6) with IC50 of 19 
µg/ml and second highest activity against chloroquine-
resistant strain (W2) IC50 24.42 µg/ml respectively. 
Notably, efficacy increased with increasing polarity of the 
mobile phase except in fraction Lk-6. The judgement for 
cytotoxic levels was made where a fraction was 
considered very toxic when CC50< 10 μg/ml, moderately 
toxic with CC50 ranging from 11-30 μg/ml, slightly toxic 
with CC50, 31-50 μg/ml, and potentially non-toxic with 
CC50> 50 μg/ml (Berthi et al., 2018). Hence, most 
fractions were potentially nontoxic with majority showing 
CC50 values >50, except Lk-4 (46.26 μg/ml). Selectivity 
indices of fractions were calculated as previously done 
(Rocha et al., 2012) and fractions generally depicted 
lower selectivity indices against D6 compared to W2. 
However, with SI>2 against both parasite strains, Lk-5, 
which also exerted the best antiplasmodial efficacy 
showed specific activity rather than toxicity (Berthi et al., 
2018). Since antimalarial drug efficacy is best assessed 
in vivo rather than in vitro, two dosages  of  each  fraction








IC50 of anti-plasmodial assay against strains tested 
(M±SD) 
CC50(µg/ml) Selectivity Indices of Fractions 
W2  (µg/ml) D6  (µg/ml) Vero E6 Cell  line SI -W2 SI-D6 
Lk-1 >100 79.41±16.61 71.21 0.7121 0.8967 
Lk-2 68.42±5.55 78.85±5.82 55.00 0.8038 0.6975 
Lk-3 45.16±9.05 30.43±0.68 64.90 1.44 2.13 
Lk-4 24.18±2.50 30.82±18.01 46.26 1.91 1.50 
Lk-5 24.42±5.95 19.45±6.20 67.13 2.75 3.45 
Lk-6 56.75±5.12 36.53±14.42 69.96 1.23 1.92 
Cq 77.86±4.09ng/ml 15.71±6.49ng/ml n/d n/d n/d 
 
IC50 –an effective concentration that inhibits 50% of the cultured parasite from hypoxanthine uptake, CC50- Drug concentration that reduces cell 




Table 3. In vivo antimalarial activity of fractions of L. kituiensis against P. berghei (ANKA 65). 
 
Fractions 
Parasite density per dose  (Mean±SD) Chemo-suppression per dose (Mean±SD) 
500 mg/kg 1000 mg/kg 500 mg/kg 1000 mg/kg 
















































Cq-Chloroquine-positive control, Placebo-Negative control- (vehicle), Parasite Density-Denotes percentage of infected erythrocytes, 
Chemosuppression- measure of drugs’ effectiveness in reducing parasite growth over the period tested, 
a, b
P≤ 0.05 level of significant difference 




(500 and 1000 mg/kg)  were screened in a mouse model 
following Peter’s suppressive test (Peters, 1975). Results 
are as shown in Table 3. 
Overall, all fractions exhibited significant antimalarial 
activity when compared to the negative control. Their 
efficacy was however insignificant in comparison with the 
positive control (chloroquine). A dose dependent activity 
was observed with the highest efficacy seen in animals 
treated with 1000 mg/kg. However, 500 mg/kg of Lk-1 
was more efficacious than it was at 1000 mg/kg. The 
dose was repeated in a separate group of animals and 
almost similar results were obtained. This scenario can 
be linked to toxicity since mortality was seen day 2 post-
infection contrary to expectation.  Additionally, the 
fraction showed a low selectivity index in-vitro alluding to 
cytotoxicity.Fraction Lk-3 was found to possess the most 
pronounced activity during in vivo testing with percentage 
chemosuppression of 80.01 at 1000 mg/kg. This was 
consistent with in vitro data in Table 2, particularly 
against D6 strain. 
Qualitative phytochemical screening was  conducted  to 
determine classes of secondary metabolites in each 
fraction (Table 4). Comparatively, Lk-3 and Lk-5 
demonstrated availability of different secondary 
metabolites, hence the efficacy observed from the 
fractions. Notably, all the fractions except Lk-6 indicated 
the presence of alkaloids. On account of outstanding in 
vivo efficacy, fraction Lk-3 was further analyzed for its 
phytochemical content using FTIR and GC-MS.  Spectral 
data are indicated in Figure 1, Tables 5 and 6 (GC-MS) 
respectively. 
Spectral results for Lk-3 complement the qualitative 
phytochemical screening depicted in Table 4. For 
instance, the presence of phenols during the qualitative 
screening was confirmed by absorbance at 1379.0 from 
the spectra. GC-MS method identified 8 compounds with 
hexatriacontane (28.75%) being the major compound 
identified followed by hentriacontane, 3-methyl (7.13%) 
and tetratetracontane (6.13%). The first compound with 
retention time 6.758 min needs further identification using 
nuclear magnetic resonance which was beyond the 
scope of  the  current  study.  Although  the  NIST  library




Table 4. Qualitative phytochemical composition of fractions. 
 
Fractions 
Secondary metabolites screened 
Alkaloids Terpenoids Phenols Tannins Glycosides 
Lk-1 + - - - + 
Lk-2 + - - - + 
Lk-3 + + + - - 
Lk-4 + - - + + 
Lk-5 + - + - + 
Lk-6 - + + - + 
 










Table 5. FTIR Spectral interpretation of Lk-3. 
 
S/N Frequency range Functional Group identified 
1 3329.3-2657.7   cm
-1
 O-H carboxylic acid 
2 1706.9 cm
-1
 C=O saturated carbonyl group  
3 1465.8 cm
-1
 C-H  methylene group from an alkane 
4 1591.2 and 1425.3 cm
-1
 C=C stretching in an aromatic ring 
5 1172.6, 1112.9, 1070.4 C-H weak bending in the aromatic ring 
6 1379.0 O-H bending due to Phenol 




suggested 1,3-Butanediol, the similarity index is so low to 
imply so. Three compounds identified have previously 
been reported to possess antimalarial activity and other 






The antimalarial activity of fractionated organic extracts of 
L. kituiensis Vatke and their cytotoxic levels have been 
revealed in this study. Moderate to low antiplasmodial 
activity was seen. This can be attributed to instability of 
the fractionated extracts which are normally protected by 
chlorophyll and/or other components in their native forms 
(Zani et al., 1997). The concerted antimalarial effects of 
the total extracts of L. kituiensis as depicted in previous 
reports could have also been compromised by the semi-
purification process during fractionation. 
Outstanding  efficacy  observed  during  in  vivo studies 
















1 6.758 Unknown  C8H14O4 (S) 174 (S) 0.99(S) 
2 10.772 2,4-Di-tert-butylphenol  C14H22O 206 0.98 
3 13.417 2-Pentadecanone, 6,10,14-trimethyl C18H36O 268 2.37 
4 14.02 Hexadecanoic acid, methyl ester  C17H34O2 270 1.91 
5 14.33 l-(+)Ascorbic acid2,6 dihexadecanoate C38H6808 652 5.88 
6 23.055 Tetratetracontane  C44H90 618 6.31 
7 26.435 Hentriacontane, 3-methyl-  C32H66 450 7.13 
8 21.594 Hexatriacontane   C36H74 506 28.75 
 




Table 7. Names and Structures of compounds with previously reported pharmacological properties identified in 
fraction Lk-3 by GC-MS. 
 












rather than in vitro suggests immunomodulatory activity 
of drugs which may be due to localization of specific 
phytochemicals including fatty acids such as linoleic 
acids, squalene and Tannins which have previously been 
reported to possess immune-stimulating properties 
(Kumaradevan et al., 2015; Chakrabarti et al., 2012). 
These class of compounds (except Tannins) were found 
to be present in fraction Lk-3 as illustrated by GC-MS 
data in Table 5. 
To the best of our knowledge, this study reports the 
antimalarial potential of fractionated extracts of L. 
kituiensis for the first time the. However, a number of 
pharmacological properties have been ascribed to the 
genus Lippia, including antimalarial, antimicrobial, 
antifungal, larvicidal, antispasmodic, analgesic, anti-
inflammatory, and antipyretic activities (Santos et al., 
2016). Numerous studies on this genus have focused on 
their essential oils (Stashenko et al., 2013). The 
promising antimalarial activity observed is consistent with 
other reports on the use of plants in the same family for 
the management of Malaria.  For example among other 
things, Lippia javanica has been reported for use  to  cure 
fever or malaria (Maroyi, 2017). Ludere et al. (2013) 
isolated a compound (Lippialactone) with antiplasmodial 
effects from aerial parts of L. javanica. In a different study 
involving plants collected from Nigeria, Lippia multiflora 
was among plant samples from 11 families collected 
based on antimalarial ethnopharmacology (Ajaiyeoba et 
al., 2006). 
The presence of secondary metabolites, especially 
alkaloids, phenolic compounds, and terpenoids could be 
responsible for the observed antimalarial activity. Quinine 
is a good example of alkaloids that have earlier been 
reported to possess antiplasmodial properties 
(Mekonnen, 2015).  Most of the compounds in fraction 
Lk-3 identified by GC-MS have been reported previously. 
Although the specific antimalarial efficacy of the identified 
compounds has not been reported before, it is worthy 
stating that these compounds have been reported in plant 
extracts of medicinal plants that are traditionally used to 
manage Malaria. For instance, hexadecanoic acid, 
methyl ester was earlier identified in whole plant extracts 
of Phyllanthus amarusa medicinal plant used to treat 





Hexadecanoic acid, methyl ester, is a polyunsaturated 
fatty acid (PUFA). These class of compounds have been 
implicated in antiplasmodial activity and are reported to 
increase with the degree of unsaturation, (Kumaratilake 
et al., 1992). These results are consisted with past 
reports of antimalarial efficacy of PUFA, where a mixture 
of Linolenic and linoleic acid showed a 96% 
chemosupression in mice infected with P. berghei 
(Melariri et al., 2012). 2,4-Di-tert-butylphenol (DTBP), a 
volatile phenolic compound is reported to possess 
antioxidant properties (Choi et al., 2013) and in vitro 
antimalarial activity at 100 mM  (Kusch et al., 2011; 
Kulangara et al., 2015). Furthermore, DTBP isolated from 
a Lactococcus sp demonstrated antifungal, antioxidant 
and cytotoxicity against cancer cell lines (Kulangara et 
al., 2015; Jayaseelan et al., 2017). The rest of the 
compounds have not been reported for antimalarial 
activity but other pharmacological importance where 
Hexatriacontane identified in essential oils of Cassia 
fistula showed significant activity against the standard 
and clinical isolates of Candida species (Irshad et al., 
2012). The observed antimalarial efficacy of Lk-3 and by 
extension the other fractions can be attributed to 
individual or synergistic activity of compounds with 





Total organic extracts of L. kituiensis Vatke were 
subjected to fractionation using Chromatographic 
techniques. Substantive antimalarial efficacy and 
potential safety of fractions from the plant have been 
revealed in this study. The classes of compounds 
attributable to the efficacy have also been made 
evidenced. Results from this study not only validate the 
traditional use of extracts of the plant to manage malaria 
but also highlights the need for research towards isolation 
and purification of novel compounds from it. Henceforth, 
it is possible that phytomedicines can be developed for 
use by local communities to manage malaria. We further 
recommend comprehensive in-vivo safety studies and 
isolation of compound(s) from fractions of this plant, 
particularly fraction Lk-3. 
 
 
CONFLICT OF INTERESTS 
 





ANOVA, Analysis of Variance; D6, Chloroquine-sensitive; 
DCM, Dichloromethane; DMSO, Dimethyl sulfoxide; 
FTIR, Fourier Trans-Infra-Red; GC-MS, Gas 
Chromatography-Mass spectrophotometry; JKUAT, 
Jomo Kenyatta  University  of  Agriculture,  Science,  and 




Technology; KBr, Potassium bromide; KEMRI, Kenya 
Medical Research Institute;  MeOH, Methanol; MTT, 3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; 
NM-AIST, National Institute of Advanced Industrial 
Science and Technology; ACUC, Animal Care and Use 
Committee; PUFA, Polyunsaturated fatty acid; SERU, 
Scientific and Ethics Review Unit; TLC, Thin layer 
chromatography plates; UV, Ultra-violet; W2, 





The authors sincerely appreciate the World Bank, 
through The African Centre for Research, Agricultural 
Advancement, Teaching Excellence and Sustainability 
(CREATES) hosted at the Nelson Mandela African 
Institution of Science and Technology (NM-AIST) for 
funding this research; Kenya Medical Research Institute 
for providing research infrastructure; the Jomo Kenyatta 
University of Agriculture, Science and Technology for 
their assistance with some aspects of the study; the 
director KEMRI for allowing the publication of this work 
and by extension the entire staff Fraternity of the Center 
for Traditional Medicine and Drug Research for their 





Ajaiyeoba EO, Abiodun OO, Falade MO, Ogbole NO, Ashidi JS (2006). 
In vitro cytotoxicity studies of 20 plants used in Nigerian antimalarial. 
Ethnomedicine 13:295-298.  
Arthur H, Joubert E, De Beer D, Malherbe CJ, Witthuhn RC (2011). 
Phenylethanoid glycosides as major antioxidants in Lippia multiflora 
herbal infusion and their stability during steam pasteurisation of plant 
material. Food Chemistry 127(2):581-588.  
Begum A, Rao K, Dutt RKG, Fathima U, Shaffath S (2017). 
Phytochemical Screening and Thin Layer Chromatography of Indian 
Asparagus Officinalis Linn. International Journal of Advanced 
Research 5(4):1520-1528.  
Bero J, Ganfon H, Jonville M-C, Frédérich M, Gbaguidi F, DeMol P, 
Quetin-Leclercq J (2009). In vitro antiplasmodial activity of plants 
used in Benin in traditional medicine to treat malaria. Journal of 
Ethnopharmacology 122(3):439-444.  
Berthi W, González A, Rios A, Blair, S, Cogollo Á, Pabón A (2018). Anti 
‑ plasmodial effect of plant extracts from Picrolemma huberi and 
Picramnia latifolia. Malaria Journal 17:1-12.  
Chakrabarti R, Kumar P, Kundu K, Sahay R, Banerjee S (2012). Fish 
and Shell fish Immunology Evaluation of immunostimulatory and 
growth promoting effect of seed fractions of Achyranthes aspera in 
common carp Cyprinus carpio and identification of active 
constituents. Fish and Shellfish Immunology 32(5):839-843.  
Chen Y, Murillo-solano C, Kirkpatrick MG, Antoshchenko T, Park H, 
Pizarro JC (2018). Repurposing drugs to target the malaria parasite 
unfolding protein response. Scientific Reports 8(1).  
Choi SJ, Kim JK, Kim HK, Harris K, Kim C-J, Park GG,Shin D-H (2013). 
2,4-Di- tert -butylphenol from Sweet Potato Protects Against 
Oxidative Stress in PC12 Cells and in Mice. Journal of Medicinal 
Food 16(11):977-983.  
de Beer T, Wells G, Burger P, Joubert F, Marechal E, Birkholtz L, Louw 
A (2012). Antimalarial Drug Discovery: In Silico Structural Biology 
and Rational Drug Design. Infectious Disorders - Drug Targets 
9(3):304-318. 
Desjardins RE, Canfield CJ, Haynes JD, Chulay JD (1979). Quantitative 




assessment of antimalarial activity in vitro by a semiautomated 
microdilution technique. Antimicrobial Agents and Chemotherapy 
16(6):710-718. 
Kumaratilake LM, Robinson BS, Ferrante A, Poulos A (1992). 
Antimalarial properties of n-3 and n-6 polyunsaturated fatty acids: in 
vitro effects on Plasmodium falciparum and in vivo effects on P. 
berghei. Journal of Clinical Investment 89(3):961-967. 
Gebrehiwot S, Shumbahri M, Eyado A, Yohannes T (2019). 
Phytochemical Screening and In Vivo Antimalarial Activity of Two 
Traditionally Used Medicinal Plants of Afar Region, Ethiopia, against 
Plasmodium berghei in Swiss Albino Mic. 
https://doi.org/10.1155/2019/4519298 
Igwe O (2015). Investigation of Bioactive Phytochemical Compounds 
from the Chloroform Extract of the Leaves of Phyllanthus amarus by 
GC-MS Technique. International Journal of Chemistry and 
Pharmaceutical Sciences 2(1):554-560. 
Imwong M, Nakeesathit S, Day NP, White NJ (2011). A review of mixed 
malaria species infections in anopheline mosquitoes. Malaria Journal 
10(1):253.  
Irshad M, Ahmad A, Zafaryab M, Ahmad F, Manzoor N, Singh M, 
Moshahid RMA (2012). Composition of Cassia fistula Oil and its 
Antifungal Activity by Disrupting Ergosterol Biosynthesis. Natural 
Product Communications 8(2):1934578X1300800233. 
Jayaseelan C, Gandhi PR, Ravindranath S, Rajasree R, Suman TY, 
Mary RR (2017). Toxicity studies of nanofabricated palladium against 
filariasis and malaria vectors. Environmental Science and Pollution 
Research 25(1):324-332. 
Kasolo JNGSB, Ojok L, Ogwal-Okeng JW (2011). Phytochemicals and 
acute toxicity of Moringa oleifera roots in mice. Journal of 
Pharmacognosy and Phytotherapy 3(3):38-42. 
Kaur M, Chadha P, Kaur S, Kaur A, Kaur R (2018). Schizophyllum 
commune induced genotoxic and cytotoxic effects in Spodoptera 
litura. Scientific Reports (March) 1-12. 
https://doi.org/10.1038/s41598-018-22919-0 
Kulangara K, Devendra L, Shilpa G, Priya S, Pandey A, Madhavan K 
(2015). International Journal of Food Microbiology from a newly 
isolated Lactococcus sp. International Journal of Food Microbiology 
211:44-50. https://doi.org/10.1016/j.ijfoodmicro.2015.06.025 
Kumaradevan G, Damodaran R, Mani P, Dineshkumar G, Jayaseelan T 
(2015). gc-ms analysis of bioactive components of ethanol leaves 
extract of Clerodendrum phlomidis (L.). American Journal of 
Biological and Phytochemical Screening 2(3):142-148. 
Landier J, Parker DM, Thu AM, Lwin KM, Delmas G, Nosten FH, 
Malaria Elimination Task Force Group (2018). Effect of generalised 
access to early diagnosis and treatment and targeted mass drug 
administration on Plasmodium falciparum malaria in Eastern 
Myanmar: an observational study of a regional elimination 
programme. The Lancet 6736(18):1-11.  
Ludere MT, Ree TV, Vleggaar R (2013). Fitoterapia Isolation and 
relative stereochemistry of lippialactone, a new antimalarial 
compound from Lippia javanica. Fitoterapia 86:188-192.  
Maroyi A (2017). Lippia javanica ( Burm . f .) Spreng: Traditional and 
Commercial Uses and Phytochemical and Pharmacological, 2017. 
Evidence-Based Complementary and Alternative Medicine Volume 
2017 |Article ID 6746071 | 34 pages | 
https://doi.org/10.1155/2017/6746071 
 Mekonnen LB (2015). In vivo antimalarial activity of the crude root and 
fruit extracts of Croton macrostachyus (Euphorbiaceae) against 
Plasmodium berghei in mice. Journal of Traditional and 
Complementary Medicine 5(3):168-173.  
Melariri P, Campbell W, Etusim P, Smith P (2012). In Vitro and in Vivo 
Antimalarial Activity of Linolenic and Linoleic Acids and their Methyl 
Esters. Advance Studies on Biology 4(7):333-349. 
Memon AH, Ismail Z, Al-Suede FSR, Aisha AFA, Hamil MSR, Saeed 
MAA, Majid AMSA (2015). Isolation, characterization, crystal 
structure elucidation of two flavanones and simultaneous RP-HPLC 
determination of five major compounds from Syzygium 
campanulatum Korth. Molecules 20(8):14212-14233.  
Mzena T, Swai H, Chacha M (2018). Antimalarial activity of 
<em>Cucumis metuliferus</em> and <em>Lippia kituiensis 
</em>against <em>Plasmodium berghei</em> infection in mice. 





Pascual ME, Slowing K, Carretero E, Sánchez MD, Villar A (2001). 
Lippia: Traditional uses, chemistry and pharmacology: A review. 
Journal of Ethnopharmacology 76(3):201-214.  
Pereira MR, Henrich PP, Bir A, Sidhu S, Johnson D, Hardink J, Fidock 
DA (2011). In Vivo and In Vitro Antimalarial Properties of 
Azithromycin-Chloroquine Combinations That Include the Resistance 
Reversal Agent Amlodipine †. Antimicrobial Agents and 
Chemotherapy 55(7):3115-3124.  
Peters W (1975). The chemotherapy of rodent malaria, XXII. The value 
of drug-resistant strains of P. berghei in screening for blood 
schizontocidal activity. Annals of Tropical Medicine and Parasitology 
69(2):155-171.  
Phillips MA, Burrows JN, Manyando C, van Huijsduijnen RH, Van 
Voorhis WC, Wells TNCC (2017). Malaria. Nature Reviews Disease 
Primers 3:17050.  
Rocha LF, Montoia A, Amorim RCN, Melo MR, Henrique MC, 
Nunomura SM, Pohlit AM (2012). Phytomedicine Comparative in vitro 
and in vivo antimalarial activity of the indole alkaloids ellipticine, 
olivacine, cryptolepine and a synthetic cryptolepine analog. European 
Journal of Integrative Medicine 20(1):71-76.  
Santos NO, Dos Pascon RC, Vallim MA, Figueiredo CR, Soares MG, 
Lago JHG, Sartorelli P (2016). Cytotoxic and Antimicrobial 
Constituents from the Essential Oil of Lippia alba (Verbenaceae). 
Medicines (Basel, Switzerland) 3(3).  
Singh B, Sung LK, Matusop A, Radhakrishnan A, Shamsul SS, Cox-
Singh J, Conway DJ (2004). A large focus of naturally acquired 
Plasmodium knowlesi infections in human beings. The Lancet 
363(9414):1017-1024.  
Stashenko EE, Mart JR, Dur DC (2013). Chromatographic and mass 
spectrometric characterization of essential oils and extracts from 
Lippia (Verbenaceae). Aromatic Plants, pp. 192–202. 
https://doi.org/10.1002/jssc.201200877 
Tona L, Mesia K, Ngimbi NP, Chrimwami B, Okond’ahoka Cimanga K, 
Vlietinck AJ (2001). In-vivo antimalarial activity of Cassia 
occidentalism Morinda morindoides and Phyllanthus niruri. Annals of 
Tropical Medicine and Parasitology 95(1):47-57. 
Van Hellemond JJ, Rutten M, Koelewijn R, Zeeman AM, Verweij JJ, 
Wismans PJ, Van Genderen PJ J (2009). Human Plasmodium 
knowlesi infection detected by rapid diagnostic tests for malaria. 
Emerging Infectious Diseases 15(9):1478-1480.  
Walker REH, Kumar S, Khan F, Pandurang M, Pal A (2015). 
Parasitology International Bioactivity-guided isolation of 
antiplasmodial constituents from Conyza. Parasitology International 
64(1):118-123.  
World Health Organization (2018). World Malaria Report 2018 ISBN 
978 92 4 156565 3. Retrieved from www.who.int/malaria 
World Malaria Day (2019). Retrieved June 27, 2019, from 
https://www.who.int/campaigns/world-malaria-day/world-malaria-day-
2019 
Wright CW, Phillipson JD (1990). Natural products and the development 
of selective antiprotozoal drugs. Phytotherapy Research 4(4):127-
139. https://doi.org/10.1002/ptr.2650040402 
Zani CL, Chiari E, Horizonte B, Federal U, Gerais DM, Horizonte B, 
Street K (1997). Anti-Plasmodial and Anti-Trypanosomal Activity of 
Synthetic. Bioorganic and Medicinal Chemistry 5(12):2185-2192. 
